StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)

Investment analysts at StockNews.com started coverage on shares of Enzo Biochem (NYSE:ENZ) in a report issued on Saturday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Price Performance

NYSE ENZ opened at $0.66 on Friday. Enzo Biochem has a one year low of $0.63 and a one year high of $1.44. The company’s 50-day simple moving average is $0.88 and its two-hundred day simple moving average is $1.04.

Enzo Biochem (NYSE:ENZ) last announced its earnings results on Monday, December 16th. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Hedge Funds Weigh In On Enzo Biochem

A number of institutional investors have recently bought and sold shares of ENZ. Renaissance Technologies LLC raised its holdings in shares of Enzo Biochem by 2.6% in the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock valued at $2,725,000 after buying an additional 64,417 shares during the period. Geode Capital Management LLC boosted its holdings in Enzo Biochem by 3.3% in the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after purchasing an additional 11,742 shares during the period. BBR Partners LLC purchased a new position in shares of Enzo Biochem in the 3rd quarter valued at about $112,000. Finally, XTX Topco Ltd grew its position in shares of Enzo Biochem by 94.5% during the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock worth $31,000 after buying an additional 13,735 shares in the last quarter. 36.90% of the stock is owned by hedge funds and other institutional investors.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.